LEADER 01531nam  2200397Ia 450 
001 9910698802503321
005 20090608142609.0
035   $a(CKB)5470000002397846
035   $a(OCoLC)374687851
035   $a(EXLCZ)995470000002397846
100   $a20090608d1998      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $esupplemental testing and the notification of consignees of donor test results for antibody to hepatitis C virus (anti-HCV)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[1998]
215   $a8 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 8, 2009).
300   $a"March 1998".
320   $aIncludes bibliographical references (page 8).
517   $aGuidance for industry 
606   $aBlood$xExamination$xGovernment policy$zUnited States
606   $aImmunoglobulins$zUnited States
606   $aHepatitis C virus$xGovernment policy$zUnited States
615  0$aBlood$xExamination$xGovernment policy
615  0$aImmunoglobulins
615  0$aHepatitis C virus$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698802503321
996   $aGuidance for industry$93434577
997   $aUNINA